Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elongation factor Tu (EF-Tu) is a highly conserved GTPase protein found in prokaryotes. It facilitates the delivery of aminoacyl-tRNA (aa-tRNA) to the A-site of the ribosome during protein synthesis. EF-Tu is essential for accurate and efficient translation elongation, ensuring that each codon on mRNA is matched with its correct tRNA. Beyond translation, bacterial EF-Tu can localize on cell surfaces where it interacts with membrane receptors and extracellular matrix components. These interactions are implicated in pathogenesis and immune evasion. In plants, plastidic/mitochondrial versions play roles in stress responses. Several antibiotics target EF-Tu, disrupting bacterial protein synthesis, making it an important drug target for antibacterial therapy development.
Several antibiotics target distinct functional states or binding sites within EF-Tu, disrupting bacterial protein synthesis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Elongation Factor Tu (EF-Tu).